Current investigations into retatrutide, a dual stimulant for GLP-1 and GIP receptors, are showing encouraging results in managing weight gain and type second-type diabetes. Preclinical data suggest a unique process https://shopretatrutidepeptide.com/2026/03/12/what-is-retatrutide-peptide/